title: Value based pricing for NHS drugs: an opportunity not to be missed?
authors.affiliation: Centre for Health Economics, University of York, York.
authors.forename: Karl
authors.initials: K
authors.lastname: Claxton
authors.forename: Andrew
authors.initials: A
authors.lastname: Briggs
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Buxton
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Culyer
authors.forename: Christopher
authors.initials: C
authors.lastname: McCabe
authors.forename: Simon
authors.initials: S
authors.lastname: Walker
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Sculpher
mesh_terms: D003365:Costs and Cost Analysis; D016527:Drug Costs; D005102:Health Expenditures; D004364:Pharmaceutical Preparations / Q000191:economics*; D013222:State Medicine / Q000191:economics*; D013678:Technology, Pharmaceutical / Q000191:economics; D006113:United Kingdom
chemical_list: D004364:Pharmaceutical Preparations